FANCI (FA Complementation Group I)

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

›

FANCI mutation	Prostate Cancer	FANCI mutation	Prostate Cancer	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3
FANCI mutation + FLT1 mutation	Squamous Cell Carcinoma of Head and Neck	FANCI mutation + FLT1 mutation	Squamous Cell Carcinoma of Head and Neck	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3

Associations(2)